Syntekabio Company
Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.
Technology:
AI based drug discovery and patient stratification, Self-developed bioinformatics tools for analyzing genomic data
Industry:
Drug Discovery, Early Drug Development
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2009-09-15
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
7
Total Funding:
183902559
Last Funding Date:
2019-12-17
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership